The use of crizotinib to inhibit the activity of met, a tyrosine kinase that is abnormal in a number of tumors. the use of erbitux and vectibix to inhibit epidermal growth factor receptors that are commonly expressed in cancer cells. the use amplichip®cyp450 assay to asses risks in course of cancer and create adequate treatment and prognosis. the use of warfarin to inhibit expression of several genes, particularly cyp2c9 and vkorc1.the use oncotypedx® assay to analyze the expression (amount of mrna) in cancer samples. the use of herceptin for the treatment of breast cancer.